(R)-4-Benzyl-2-(1,8-naphthyridin-2-yl)-4,5-dihydrooxazole, 98%, 250mg

tert-butyl methyl ether, min. 99.5%, for synthesis, 10 l, white blister

N-SUCCINIMIDYL 6-(2,4-DINITROANILINO)HEXANOATE, 95.0%, 200mg

7-methyl-[1,2,4]triazolo[1,5-a]pyridin-2-amine, 95+%, 50g

Quinolin-2(1H)-one, 98.0%, 10g

1-Ethynyl-1-methoxycyclohexane, 98%, 100mg

(S)-2-((tert-Butoxycarbonyl)amino)-3-(3,4-dichlorophenyl)propanoic acid, 95.0%, 10g

Potassium p-Toluenethiosulfonate>98.0%(HPLC)5g

6-(Ethanesulfonyl)pyridine-3-boronic acid, 98%, 250mg

5-CHLORO-2-FLUORO-4-HYDROXYBENZALDEHYDE, 95.0%, 5g

(R)-4-Aminomethyl-thiazolidine-3-carboxylic acidtert-butyl ester, 95.0%, 1g

2,4-Dichloro-6,7-dihydro-5H-cyclopenta[d]pyrimidine, 95.0%, 100g

tert-Butyl 2-cyanomorpholine-4-carboxylate, 95.0%, 250mg